Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Markusse

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Journal of Medical Virology|December 1, 1993
Characterization of Epstein-Barr viral strains in parotid gland saliva and peripheral blood of patients with primary Sjögren's syndrome and healthy EBV carriersM A Oosterveer, H M Markusse, E T Lennette, et al.
Arthritis and Rheumatism|October 1, 1994
Somatostatin receptor imaging. The presence of somatostatin receptors in rheumatoid arthritisP M Vanhagen, H M Markusse, S W Lamberts, et al.
Rheumatology (Oxford, England)|April 20, 2001
Peptidoglycan from sterile human spleen induces T-cell proliferation and inflammatory mediators in rheumatoid arthritis patients and healthy subjectsI A Schrijver, M J Melief, H M Markusse, et al.
Annals of the Rheumatic Diseases|September 19, 1998
Fatigue in primary Sjögren's syndromeP J Barendregt, M R Visser, E M Smets, et al.
Rheumatology (Oxford, England)|November 16, 2001
Bone turnover, joint damage and bone mineral density in early rheumatoid arthritis treated with combination therapy including high-dose prednisoloneA C Verhoeven, M Boers, J M te Koppele, et al.
Annals of the Rheumatic Diseases|December 1, 1999
Parasympathetic failure does not contribute to ocular dryness in primary Sjögren's syndromeP J Barendregt, A H van Den Meiracker, H M Markusse, et al.
Cancer|May 1, 1987
Ectopic production of 1,25-dihydroxyvitamin D by B-cell lymphoma as a cause of hypercalcemiaA H Mudde, H van den Berg, P G Boshuis, et al.
Clinical and Experimental Immunology|February 13, 2001
Reduced systemic IgG levels against peptidoglycan in rheumatoid arthritis (RA) patientsI A Schrijver, Y A De Man, M J Melief, et al.
Lancet (London, England)|February 10, 1996
Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritisS ten Wolde, F C Breedveld, J Hermans, et al.
Annals of the Rheumatic Diseases|August 15, 2001
Involvement of the peripheral nervous system in primary Sjögren's syndromeP J Barendregt, M J van den Bent, V J van Raaij-van den Aarssen, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Journal of Medical Virology|December 1, 1993
Characterization of Epstein-Barr viral strains in parotid gland saliva and peripheral blood of patients with primary Sjögren's syndrome and healthy EBV carriersM A Oosterveer, H M Markusse, E T Lennette, et al.
Arthritis and Rheumatism|October 1, 1994
Somatostatin receptor imaging. The presence of somatostatin receptors in rheumatoid arthritisP M Vanhagen, H M Markusse, S W Lamberts, et al.
Rheumatology (Oxford, England)|April 20, 2001
Peptidoglycan from sterile human spleen induces T-cell proliferation and inflammatory mediators in rheumatoid arthritis patients and healthy subjectsI A Schrijver, M J Melief, H M Markusse, et al.
Annals of the Rheumatic Diseases|September 19, 1998
Fatigue in primary Sjögren's syndromeP J Barendregt, M R Visser, E M Smets, et al.
Rheumatology (Oxford, England)|November 16, 2001
Bone turnover, joint damage and bone mineral density in early rheumatoid arthritis treated with combination therapy including high-dose prednisoloneA C Verhoeven, M Boers, J M te Koppele, et al.
Annals of the Rheumatic Diseases|December 1, 1999
Parasympathetic failure does not contribute to ocular dryness in primary Sjögren's syndromeP J Barendregt, A H van Den Meiracker, H M Markusse, et al.
Cancer|May 1, 1987
Ectopic production of 1,25-dihydroxyvitamin D by B-cell lymphoma as a cause of hypercalcemiaA H Mudde, H van den Berg, P G Boshuis, et al.
Clinical and Experimental Immunology|February 13, 2001
Reduced systemic IgG levels against peptidoglycan in rheumatoid arthritis (RA) patientsI A Schrijver, Y A De Man, M J Melief, et al.
Lancet (London, England)|February 10, 1996
Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritisS ten Wolde, F C Breedveld, J Hermans, et al.
Annals of the Rheumatic Diseases|August 15, 2001
Involvement of the peripheral nervous system in primary Sjögren's syndromeP J Barendregt, M J van den Bent, V J van Raaij-van den Aarssen, et al.
Pageof 6